Role of TGF-β signaling in the mechanisms of tamoxifen resistanceCYTOKINE & GROWTH FACTOR REVIEWSIF11.82021-12-0110PREAI
TGF-βRI contributes to tamoxifen response in luminal B breast cancer with HER2-negative phenotypeANNALS OF ONCOLOGYIF65.42021-10-010OA
ERα heterogeneous expression and the TGF-βRI status in the tumour predicted tamoxifen resistanceANNALS OF ONCOLOGYIF65.42021-03-011OA
Different profile of receptor tyrosine kinases expression in breast cancer molecular subtypesANNALS OF ONCOLOGYIF65.42020-10-010OAAI
Coexpression of PI3K/Akt signaling components and breast stem cells markers: Potential contributions in resistance to tamoxifen treatmentANNALS OF ONCOLOGYIF65.42020-09-010OAAI
Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancerCLINICAL AND EXPERIMENTAL MEDICINEIF3.52019-09-2712PREAI
Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapyMOLECULAR AND CELLULAR BIOCHEMISTRYIF3.72017-12-1118PREAI
The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifenCLINICAL AND EXPERIMENTAL MEDICINEIF3.52016-05-258PREAI
Impact of ERα expression status and ESR1 genetic variation on progression in tamoxifen-treated breast cancer patientsCANCER RESEARCHIF16.62014-10-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向